Kevin Schwartz

Adjunct Scientist (Full Status)

ICES Affiliation

ICES UofT
Populations & Public Health Research Program

Phone
647-260-7629

Biography

Contact Kevin Schwartz

@kevin_kls

Education

Diploma in Tropical Medicine and Hygiene, The Gorgas Course of Tropical Medicine
FRCPC, Infectious Diseases, University of Toronto
FRCPC, Pediatrics, University of Calgary
MSc, Clinical Epidemiology, University of Toronto
MD, University of Toronto

Research Focus

Drug prescribing behaviour
Infectious diseases

Other Affiliations

Infection Prevention and Control (IPAC) and Antimicrobial Stewardship Physician, Public Health Ontario
Assistant Professor, Dalla Lana School of Public Health, University of Toronto
Infectious Disease Consultant, St. Joseph's Health Centre

Recent ICES Grants

Incidence and risk factors of inappropriate antibiotic prescribing and related adverse health outcomes among Ontario long-term care residents and marginalized older community-dwelling adults with COVID-19 (I-CARE)

Principal investigators: Daneman N, MacFadden DR, Maxwell CJ, Mishra S, Schwartz KL
Co-investigators: Brooks JI, Bowdish DM, Bronskill SE, Burrows LL, Langford BJ, Leung E, Leung V, Manuel DG, McGeer AJ, Morris AM, Nott C, Raybardhan S, So M, Soucy J
Canadian Institutes of Health Research, Operating Grant
2021-2022; $308,904
The prevention of group B streptococcal (GBS) disease in infants

Principal investigators: Crowcroft N, Fell D, Sander B
Co-investigators: Barrett J, Bolotin S, Brown KA, Fittipaldi NV, Mcgeer AJ, Murti M, Sadarangani M, Schwartz KL, Wilson K
Canadian Institutes of Health Research, Project Grant
2019-2022; $409,276
Comprehensive Ontario Microbiology laBoratory Administrative daTa for AntiMicrobial Resistance (COMBAT-AMR)

Principal investigators: Brown KA, Daneman N
Co-investigators: Sander B, Schwartz KL, Stukel T
Canadian Institutes of Health Research, Project Scheme Grant
2018-2021; $608,176

Recent ICES Publications

3/21/2023

Evaluating the impact of statin use on influenza vaccine effectiveness and influenza infection in older adults

Chung H, Campitelli MA, Buchan SA, Campigotto A, Chen B, Crowcroft NS, Dubey V, Gubbay JB, Karnauchow T, Katz K, McGeer AJ, McNally JD, Mubareka S, Murti M, Richardson DC, Rosella LC, Schwartz KL, Smieja M, Zahariadis G, Kwong JC. Clin Infect Dis. 2023; Mar 21 [Epub ahead of print]. DOI: https://doi.org/10.1093/cid/ciad148

3/7/2023

Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes

Grewal R, Nguyen L, Buchan SA, Wilson SE, Nasreen S, Austin PC, Brown KA, Fell DB, Gubbay JB, Schwartz KL, Tadrous M, Wilson K, Kwong JC. Nat Commun. 2023; 14(1):1273. Epub 2023 Mar 7. DOI: https://doi.org/10.1038/s41467-023-36566-1

3/3/2023

COVID-19 vaccine effectiveness against Omicron infection and hospitalization

Piché-Renaud PP, Swayze S, Buchan SA, Wilson SE, Austin PC, Morris SK, Nasreen S, Schwartz KL, Tadrous M, Thampi N, Wilson K, KwongJC; Immunization Research Network (CIRN) Provincial Collaborative Investigators. Pediatrics. 2023; Mar 3 [Epub ahead of print]. DOI: https://doi.org/10.1542/peds.2022-059513

See more ICES Publications

News coverage

CTV News2/13/2023Article

Kevin Schwartz

Education

Research Focus

Other Affiliations

Recent ICES Grants

Incidence and risk factors of inappropriate antibiotic prescribing and related adverse health outcomes among Ontario long-term care residents and marginalized older community-dwelling adults with COVID-19 (I-CARE)

The prevention of group B streptococcal (GBS) disease in infants

Comprehensive Ontario Microbiology laBoratory Administrative daTa for AntiMicrobial Resistance (COMBAT-AMR)

Recent ICES Publications

Evaluating the impact of statin use on influenza vaccine effectiveness and influenza infection in older adults

Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes

COVID-19 vaccine effectiveness against Omicron infection and hospitalization

News coverage

Paxlovid medication lowers risk of COVID-19 death, hospitalization: study

Paxlovid should only be prescribed to those with COVID that are high risk of severe outcomes: study

Infections like flu, UTI can put you at higher risk for heart attack